Bone geometry and density according to menstrual function in endurance athletes by Duckham, R. et al.
	 	
	
 
This is the published version 
 
   
Duckham, R., Peirce, N., Summers, G., Cameron, N. and Brooke-Wavell, K. 
2009, Bone geometry and density according to menstrual function in 
endurance athletes, Journal of sports sciences, vol. 27, no. Supp 1, pp. 40-
40. 
 
 
 
 
 
 
Available from Deakin Research Online 
 
http://hdl.handle.net/10536/DRO/DU:30067026	
	
	
	
 
 
 
 
Reproduced with the kind permission of the copyright owner 
 
 
 
 
 
 
 
 
Copyright: 2009, Taylor and Francis 
 
 
 
D5
Bone geometry and density according to
menstrual function in endurance athletes
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Loughborough University, 2Nottingham University
Hospitals Trust and English Institute of Sport, and
3Derby Hospitals Trust, UK
Exercise can increase bone density and strength,
but in amenorrhoeic athletes this may be counter-
acted by oestrogen deficiency, resulting in low
bone mineral density (BMD) compared to eume-
norrhoeic athletes. Bone strength is determined by
bone geometry as well as BMD. It is not known
whether the low BMD in amenorrhoeic athletes is
accompanied by structural differences such as
increased bone diameter. The purpose of this
study was thus to compare bone density and
geometry of female endurance athletes according
to menstrual function.
Following institutional and NHS ethical approval,
52 female endurance athletes were recruited. Bone
mineral density (BMD) and bone mineral content
(BMC) were measured at the spine, hip and radius
using dual X-ray absorptiometry (DXA) and hip
geometric parameters cross-sectional moment of
inertia (CSMI), cross-sectional area (CSA) and
minimum femoral neck width were estimated. Men-
strual function was assessed by questionnaire and
defined as oligo/amenorrhoeic (9 periods year71),
eumenorrhoeic (10 periods year71) or hormonal
contraceptive (HC) use. A one-way ANOVA com-
pared mean BMD and bone geometry according to
menstrual function.
Thirty-one percent of women used HC, 31% were
eumenorrhoeic and 38% oligo/amenorrhoeic. No
significant differences were found in height
(P¼ 0.602), weight (P¼ 0.240) and age (P¼ 0.999)
between groups. Oligo/amenorrhoeic athletes differed
significantly from eumenorrhoeic athletes in femoral
neck BMD (oligo/amenorrheoic, mean 1.02 g cm72,
s¼ 0.11; eumenorrhoeic mean 1.14 g cm72, s¼ 0.10;
HC: mean 1.09 g cm72, s¼ 0.10; P¼ 0.003), BMC
(oligoamenorrhoeic mean 4.82 g, s¼ 0.60; eumenor-
rhoeic mean 5.27 g, s¼ 0.52; HC mean 5.01 g, s¼
0.46; P¼ 0.04) and CSA (oligoamenorrhoeic mean
148 cm2, s¼ 17; eumenorrhoeic mean 163 cm2,
s¼ 16; HC mean 155 cm2, s¼ 13; P¼ 0.03),
but CSMI and femoral neck width were similar
between groups. There were no significant differences
between HC and other groups. Spine and radius
BMD did not differ significantly according to
menstrual function.
These data are consistent with past reports of
substantially lower BMD and BMC at the hip
in amenorrhoeic than eumenorrhoeic athletes
although lower spine and radius BMD were not
evident in this study. CSMI and hence strength in
bending was maintained despite lower bone miner-
al density and cross-sectional area in amenorrhoeic
athletes.
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